Clinical Trials Directory

Trials / Conditions / Female Sexual Arousal Disorder

Female Sexual Arousal Disorder

11 registered clinical trials studyying Female Sexual Arousal Disorder — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingEvaluation of the Efficacy in Increasing Sexual Arousal, Safety and Tolerability of BZ371A in Women With Sexua
NCT06651541
Biozeus Biopharmaceutical S.A.Phase 2
RecruitingEvaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder
NCT06116045
Biozeus Biopharmaceutical S.A.Phase 2
CompletedExamining Caffeine as a Treatment for Antidepressant-induced Arousal Dysfunction in Women
NCT05685407
University of Texas at AustinPhase 1
UnknownMulti-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients Wi
NCT04948151
Strategic Science & Technologies, LLCPhase 2
UnknownClinical Trial to Investigate the Effectiveness of a Dietary Supplement in Increasing Libido and Sexual Functi
NCT03820453
Kern Pharma, S.L.N/A
TerminatedSexual Penetration Pain in Postmenopausal Women: A Topical Botanical Drug Treatment
NCT03682601
GTO Pharmaceutical, LLCPhase 2
CompletedHeart Rate Variability Biofeedback for Female Sexual Arousal Disorder
NCT02958176
University of Texas at AustinN/A
CompletedBremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disor
NCT01382719
Palatin Technologies, IncPhase 2
TerminatedAlprostadil (FemLife Gel) in the Treatment of Female Sexual Arousal Disorder
NCT00572377
Cedars-Sinai Medical CenterPhase 1
CompletedEffects of Early Abuse on Adult Intimate Relationships
NCT01803802
University of Texas at AustinN/A
CompletedStudy to Investigate Effect of Sildenafil on Clitoral Engorgement as Measured by Magnetic Resonance Imaging (M
NCT00640458
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Phase 2